108 related articles for article (PubMed ID: 8319176)
1. Noninvasive follow-up of platinum pharmacokinetics in the skin of patients on cisplatin chemotherapy.
Gorodetsky R; Mou X; Vexler A; Kaufman B; Catane R; Loewenthal E
Cancer; 1993 Jul; 72(2):446-54. PubMed ID: 8319176
[TBL] [Abstract][Full Text] [Related]
2. A sensitive noninvasive analysis of Pt in external tissues. Followup of Pt deposition following cisplatin treatment.
Gorodetsky R; Vexler A; Mou X; Kaufman B; Loewenthal E
Med Phys; 1993; 20(4):1007-12. PubMed ID: 8413007
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
[TBL] [Abstract][Full Text] [Related]
4. Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin.
Leone R; Fracasso ME; Soresi E; Cimino G; Tedeschi M; Castoldi D; Monzani V; Colombi L; Usari T; Bernareggi A
Cancer Chemother Pharmacol; 1992; 29(5):385-90. PubMed ID: 1312907
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of bronchial arterial infusion of CDDP for the treatment of lung cancer--research on the platinum concentration in the tumor and pulmonary parenchyma].
Murakami M
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Jul; 49(7):880-91. PubMed ID: 2552404
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
Najjar TA; Saad SY
Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
Fracasso ME; Apostoli P; Benoni G; Bonetti A; Griso C; Leone R
Drugs Exp Clin Res; 1987; 13(6):367-72. PubMed ID: 3652926
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.
Dominici C; Petrucci F; Caroli S; Alimonti A; Clerico A; Castello MA
J Clin Oncol; 1989 Jan; 7(1):100-7. PubMed ID: 2909663
[TBL] [Abstract][Full Text] [Related]
10. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
Los G; Mutsaers PH; Lenglet WJ; Baldew GS; McVie JG
Cancer Chemother Pharmacol; 1990; 25(6):389-94. PubMed ID: 2311166
[TBL] [Abstract][Full Text] [Related]
11. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
Boer H; Proost JH; Nuver J; Bunskoek S; Gietema JQ; Geubels BM; Altena R; Zwart N; Oosting SF; Vonk JM; Lefrandt JD; Uges DR; Meijer C; de Vries EG; Gietema JA
Ann Oncol; 2015 Nov; 26(11):2305-10. PubMed ID: 26347114
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors.
Bonetti A; Franceschi T; Apostoli P; Messori A; Sperotto L; Cetto GL; Molino A; Leone R
Ther Drug Monit; 1995 Feb; 17(1):25-32. PubMed ID: 7725373
[TBL] [Abstract][Full Text] [Related]
13. [Studies on pharmacokinetics of platinum after internal iliac artery infusion of cisplatin in rabbits].
Kanamori Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan; 45(1):31-7. PubMed ID: 8436840
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser.
Milano G; Troger V; Courdi A; Fontana X; Chauvel P; Lagrange JL
Cancer Chemother Pharmacol; 1990; 27(1):55-9. PubMed ID: 2245493
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.
Pendyala L; Greco W; Cowens JW; Madajewicz S; Creaven PJ
Cancer Chemother Pharmacol; 1983; 11(1):23-8. PubMed ID: 6883623
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
Tanaka T; Masuda H; Naito M; Tamai H
Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
[TBL] [Abstract][Full Text] [Related]
18. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
Hospers GA; de Vries EG; Mulder NH
Br J Cancer; 1990 Jan; 61(1):79-82. PubMed ID: 2153398
[TBL] [Abstract][Full Text] [Related]
19. Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.
Hopfer SM; Ziebka L; Sunderman FW; Sporn JR; Greenberg BR
Ann Clin Lab Sci; 1989; 19(6):389-96. PubMed ID: 2690729
[TBL] [Abstract][Full Text] [Related]
20. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer.
Lagrange JL; Bondiau PY; Tessier E; Chauvel P; Renée N; Etienne MC; Milano G
Int J Cancer; 1996 Nov; 68(4):452-6. PubMed ID: 8945615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]